Pharmacologic Class Information
|Pharmacologic Name||Increased Platelet Aggregation|
|Pharmacologic Concept||Physiologic Effects - [PE]|
|Pharmacologic Concept Description||This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.|
NDC Products with Increased Platelet Aggregation
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Increased Platelet Aggregation [PE].
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|68982-182||Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human)||Non-Proprietary Name: Von Willebrand Factor/coagulation Factor Viii Complex (human)||Powder, For Solution||Intravenous||Octapharma Usa Inc||ACTIVE|